Cholinergic function modulators claimed for use in nicotine addiction and other disorders by Pfizer Oct. 18, 2001
Two recent clinical studies do not support the use of dopamine D1/5 antagonists in cocaine abuse July 27, 2001
Xenova receives FDA approval to resume clinical trials with anticocaine addiction vaccine July 10, 2001
Phase II Naltrel data for alcohol and heroin addiction presented at Drug Dependence meeting June 21, 2001
RSS